Neurotech International Limited Stock: price and insider trades · Australia

Every trade that managers of Neurotech International Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. Between 18 October 2025 and 18 October 2026, 5 insiders published 5 filings.

Every open-market trade in the period is a purchase: 1 purchase worth €68k, from 1 insider, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €68k, disclosed on 6 October 2026, or 0.59% of market capitalisation. On the buying side, the filings list 1 senior executive among the declarants.

The last purchase on record was published on 6 October 2026, which is 11 days ago.

With 5 filings in twelve months, the company is more active than the median of 3 filings across the 2,526 companies we follow on the same exchange. Since 2026, the database holds 1 purchase and no sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from ASX disclosures alone and does not predict where the share price will go.